Scarica l'app Stockscreener
33.23
1.90%
0.62
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$32.61
Aprire:
$32.63
Volume 24 ore:
543.04K
Relative Volume:
0.61
Capitalizzazione di mercato:
$1.67B
Reddito:
$203.27M
Utile/perdita netta:
$-4.66M
Rapporto P/E:
-332.30
EPS:
-0.1
Flusso di cassa netto:
$3.47M
1 W Prestazione:
-4.87%
1M Prestazione:
+7.44%
6M Prestazione:
+125.14%
1 anno Prestazione:
+83.19%
Intervallo 1D:
$32.37
$34.19
Intervallo di 1 settimana:
$30.98
$35.05
Portata 52W:
$9.215
$36.00
Axogen Inc Stock (AXGN) Company Profile
Nome
Axogen Inc
Settore
Industria
Telefono
(386) 462-6817
Indirizzo
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
33.23 | 1.64B | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-01 | Iniziato | Mizuho | Outperform |
| 2025-03-17 | Iniziato | Lake Street | Buy |
| 2024-07-01 | Iniziato | Raymond James | Outperform |
| 2022-11-11 | Ripresa | Jefferies | Buy |
| 2022-05-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | Guggenheim | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Iniziato | Canaccord Genuity | Buy |
| 2018-03-02 | Reiterato | Lake Street | Buy |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Iniziato | Jefferies | Buy |
| 2017-11-21 | Reiterato | Lake Street | Buy |
| 2017-07-31 | Iniziato | Leerink Partners | Outperform |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Iniziato | ROTH Capital | Buy |
| 2016-11-22 | Aggiornamento | Lake Street | Hold → Buy |
| 2016-11-07 | Reiterato | Wedbush | Outperform |
| 2016-11-03 | Downgrade | Lake Street | Buy → Hold |
| 2016-08-04 | Reiterato | Wedbush | Outperform |
| 2014-05-14 | Iniziato | Dawson James | Buy |
| 2013-10-31 | Reiterato | Ladenburg Thalmann | Buy |
Mostra tutto
Axogen Inc Borsa (AXGN) Ultime notizie
Lobbying Update: $15,000 of AXOGEN CORPORATION lobbying was just disclosed - Quiver Quantitative
Is Axogen Inc. stock a good pick for beginnersEarnings Overview Summary & Smart Investment Allocation Tips - mfd.ru
Liquidity Mapping Around (AXGN) Price Events - Stock Traders Daily
Will Axogen Inc. outperform tech stocksJuly 2025 Price Swings & Weekly Stock Breakout Alerts - mfd.ru
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - The Manila Times
Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewswire Inc.
Breakeven Is Near for Axogen, Inc. (NASDAQ:AXGN) - Yahoo Finance
Aug Levels: What is the implied volatility of ORKAJuly 2025 EndofMonth & Weekly Top Stock Performers List - baoquankhu1.vn
Volatility Watch: Can Mercantile Bank Corporation stock outperform in a bear market2025 Year in Review & Verified Technical Signals - baoquankhu1.vn
Bessemer Group Inc. Purchases Shares of 810,951 AxoGen, Inc. $AXGN - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Brown Capital Management LLC Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Sets New 1-Year HighHere's Why - MarketBeat
Y Intercept Hong Kong Ltd Lowers Holdings in AxoGen, Inc. $AXGN - MarketBeat
Axogen (AXGN) Is Up 6.2% After Expanding Financing Capacity With Universal Shelf RegistrationHas The Bull Case Changed? - simplywall.st
Why (AXGN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Analyst Upgrade: How does Axogen Inc correlate with Nasdaq2025 Momentum Check & Weekly High Return Opportunities - baoquankhu1.vn
AxoGen, Inc. (AXGN) Stock Analysis: Exploring a 23.5% Revenue Growth and 8.82% Upside Potential - DirectorsTalk Interviews
Axogen Inc (AXGN) Trading Down 2.86% on Jan 28 - GuruFocus
Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and Viking Therapeutics (VKTX) - The Globe and Mail
Axogen stock hits 52-week high at 34.79 USD By Investing.com - Investing.com Australia
Aug Levels: Is Axogen Inc a play on infrastructure spendingWeekly Trading Summary & Expert Approved Trade Ideas - baoquankhu1.vn
AxoGen (NASDAQ:AXGN) Sets New 52-Week High Following Analyst Upgrade - MarketBeat
Axogen Inc (AXGN) Trading 4.65% Higher on Jan 26 - GuruFocus
Axogen stock hits 52-week high at 34.79 USD - Investing.com
Income Plays: Is DESP on track to beat earningsRate Hike & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Axogen, Inc. (NASDAQ:AXGN) On The Verge Of Breaking Even - 富途牛牛
A Look At Axogen (AXGN) Valuation After Its Upsized US$124 Million Equity Offering - Yahoo Finance
Axogen Upsized Equity Raise Shifts Debt Profile And Valuation Focus - Sahm
Is Axogen Inc.’s growth already priced inJuly 2025 Technicals & Fast Entry and Exit Trade Plans - mfd.ru
AxoGen (NASDAQ:AXGN) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Axogen (AXGN) Is Up 5.8% After Upsized Equity Raise and Debt PaydownWhat's Changed - Yahoo Finance
AxoGen Announces Equity Offering to Repay Term Loan - The Globe and Mail
Axogen Signs Underwriting Agreement With Wells Fargo Securities and Mizuho Securities USA - TradingView
Axogen (AXGN) prices stock offering and targets $69.7M term loan payoff - Stock Titan
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
AxoGen (NASDAQ:AXGN) Shares Gap DownTime to Sell? - MarketBeat
Axogen Shares Drop After Pricing $124 Million Stock Offering - marketscreener.com
Axogen plans $85 million stock offering to repay debt By Investing.com - Investing.com Australia
Axogen stock dips after pricing $124M offering - MSN
Axogen (AXGN) Increases Stock Offering to $124 Million - GuruFocus
Axogen (AXGN) Shares Decline After Upsized Public Offering - GuruFocus
Axogen prices upsized public offering of common stock at $31 per share - Investing.com Nigeria
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock - The Manila Times
Surgical nerve repair company Axogen prices $124M stock sale to pay off term loan - Stock Titan
Axogen Announces Pricing Of Upsized $124 Million Public Offering Of Common Stock - TradingView
Axogen announces proposed $85M public stock offering; shares down - MSN
AXGN stock rises pre-market after FDA approves nerve repair graft - MSN
Axogen stock falls after $85 million share offering announcement By Investing.com - Investing.com Nigeria
Axogen Inc Azioni (AXGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Axogen Inc Azioni (AXGN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wendell Amy McBride | Director |
Dec 16 '25 |
Sale |
29.31 |
43,684 |
1,280,465 |
93,826 |
| Weiler Kathy Johnson | Director |
Dec 16 '25 |
Option Exercise |
6.99 |
40,073 |
280,150 |
46,653 |
| Weiler Kathy Johnson | Director |
Dec 16 '25 |
Sale |
29.55 |
46,653 |
1,378,476 |
0 |
| Hartley Lindsey Marie | CFO |
Dec 15 '25 |
Option Exercise |
8.27 |
14,812 |
122,495 |
46,188 |
| Hartley Lindsey Marie | CFO |
Dec 15 '25 |
Sale |
29.86 |
14,812 |
442,294 |
31,376 |
1.33%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):